Source: Breathe, 14 (4) 345; 10.1183/20734735.026518
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Katerina Antoniou, Athina Trachalaki, Eleni Bibaki, Venerino Poletti. Assembly 12: interstitial lung diseases. Breathe, 14 (4) 345; 10.1183/20734735.026518

Member's Comments

No comment yet.

Related content which might interest you: Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019 Year: 2019 Markers of injury and fibrosis in occupational interstitial lung diseases (OILD) Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 B-cell infiltration varies among patients with interstitial lung diseases Source: International Congress 2016 – ILD pathogenesis Year: 2016 Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Outcomes in interstitial lung diseases (ILDs) Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Asbestos-related disorders (ARDs): Influence of pleural plaques and pulmonary fibrosis due to asbestos exposure on lung function decline (LFD) Source: International Congress 2014 – ILDs 5 Year: 2014 HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders Source: International Congress 2014 – IPF and surroundings Year: 2014 Evolution of an interstitial lung disease MDT: 5.5 years of data Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Study of factors affecting mortality in ILD cases over 2 years Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2016 – SW20 Radiological-pathological correlations for clinicians Year: 2016 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2015 – EW12 Radiological – pathological correlations for clinicians Year: 2015 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2016 – SW18 Radiological-pathological correlations for clinicians Year: 2016 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2016 – SW16 Radiological-pathological correlations for clinicians Year: 2016 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2015 – EW8 Radiological – pathological correlations for clinicians Year: 2015 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2015 – EW10 Radiological – pathological correlations for clinicians Year: 2015 Assembly 5: airway diseases Source: Breathe 2017; 13: 59 Year: 2017 Genetics of fibrosing lung diseases Source: Eur Respir J 2005; 25: 915-927 Year: 2005 Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001 "Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease" Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014